| - GRCh37:
- ChrMT:5782-13922
- GRCh38:
- ChrMT:5782-13922
| MT-ND4L, MT-ND5, MT-TC, MT-TD, MT-TR, MT-TS1, MT-TK, MT-TL2, MT-TS2, MT-TH, MT-TY, MT-ND4, MT-TG, MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-ND3 | | Primary dilated cardiomyopathy, Macrocytic dyserythropoietic anemia | Likely pathogenic (Nov 4, 2014) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:5794-14876
- GRCh38:
- ChrMT:5794-14876
| MT-CYB, MT-ND3, MT-TL2, MT-TR, MT-TS1, MT-TS2, MT-TY, MT-ATP6, MT-ATP8, MT-ND4, MT-ND4L, MT-ND5, MT-TG, MT-TH, MT-ND6, MT-TC, MT-TD, MT-CO1, MT-CO2, MT-CO3, MT-TE, MT-TK | | Primary dilated cardiomyopathy, Macrocytic dyserythropoietic anemia | Likely pathogenic (Nov 4, 2014) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:6468-15586
- GRCh38:
- ChrMT:6468-15586
| MT-ATP6, MT-ATP8, MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-TD, MT-TE, MT-TG, MT-TH, MT-TK, MT-TL2, MT-TR, MT-TS1, MT-TS2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:7126-13988
- GRCh38:
- ChrMT:7126-13988
| MT-CO1, MT-CO2, MT-CO3, MT-ND3, MT-TD, MT-TG, MT-TL2, MT-TR, MT-TS1, MT-TS2, MT-ND4, MT-ND4L, MT-ND5, MT-TH, MT-TK, MT-ATP6, MT-ATP8 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8290-13040
- GRCh38:
- ChrMT:8290-13040
| MT-TR, MT-TS2, MT-ATP6, MT-ATP8, MT-CO3, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-TG, MT-TH, MT-TK, MT-TL2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8350-13450
- GRCh38:
- ChrMT:8350-13450
| MT-TR, MT-TS2, MT-TK, MT-TL2, MT-ATP6, MT-ATP8, MT-CO3, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-TG, MT-TH | | Pearson syndrome | Pathogenic (Jun 12, 2019) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8470-13446
- GRCh38:
- ChrMT:8470-13446
| MT-TG, MT-TH, MT-TL2, MT-TR, MT-TS2, MT-CO3, MT-ND3, MT-ND4, MT-ATP6, MT-ATP8, MT-ND4L, MT-ND5 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8480-13440
- GRCh38:
- ChrMT:8480-13440
| MT-ATP6, MT-ATP8, MT-CO3, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-TR, MT-TS2, MT-TG, MT-TH, MT-TL2 | | Pearson syndrome | Pathogenic (Jun 12, 2019) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8585-12965
- GRCh38:
- ChrMT:8585-12965
| MT-ATP6, MT-CO3, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-TG, MT-TH, MT-TL2, MT-TR, MT-TS2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8815-13722
- GRCh38:
- ChrMT:8815-13722
| MT-ATP6, MT-CO3, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-TG, MT-TH, MT-TL2, MT-TR, MT-TS2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:8839-14895
- GRCh38:
- ChrMT:8839-14895
| MT-ATP6, MT-CO3, MT-CYB, MT-ND5, MT-ND6, MT-TE, MT-TG, MT-TS2, MT-ND3, MT-ND4, MT-ND4L, MT-TH, MT-TL2, MT-TR | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:10105-15066
- GRCh38:
- ChrMT:10105-15066
| MT-CYB, MT-ND3, MT-ND4, MT-TH, MT-TL2, MT-TR, MT-TS2, MT-ND4L, MT-ND5, MT-ND6, MT-TE | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:10947-15537
- GRCh38:
- ChrMT:10947-15537
| MT-TL2, MT-TS2, MT-CYB, MT-ND4, MT-ND5, MT-ND6, MT-TE, MT-TH | | Pearson syndrome | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- ChrMT:11263-15374
- GRCh38:
- ChrMT:11263-15374
| MT-ND6, MT-TE, MT-TH, MT-CYB, MT-ND4, MT-ND5, MT-TL2, MT-TS2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:12114-14420
- GRCh38:
- ChrMT:12114-14420
| MT-ND4, MT-ND5, MT-ND6, MT-TH, MT-TL2, MT-TS2 | | Mitochondrial disease | Pathogenic (May 22, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:12338
- GRCh38:
- ChrMT:12338
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12340
- GRCh38:
- ChrMT:12340
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12341
- GRCh38:
- ChrMT:12341
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12344
- GRCh38:
- ChrMT:12344
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12346
- GRCh38:
- ChrMT:12346
| MT-ND5 | | not provided, Leigh syndrome | Benign/Likely benign (Oct 17, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:12349
- GRCh38:
- ChrMT:12349
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12352
- GRCh38:
- ChrMT:12352
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12358
- GRCh38:
- ChrMT:12358
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12361
- GRCh38:
- ChrMT:12361
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12362
- GRCh38:
- ChrMT:12362
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12367
- GRCh38:
- ChrMT:12367
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12372
- GRCh38:
- ChrMT:12372
| MT-ND5 | | not specified, Mitochondrial disease | Conflicting interpretations of pathogenicity (May 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrMT:12373
- GRCh38:
- ChrMT:12373
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12382
- GRCh38:
- ChrMT:12382
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12383
- GRCh38:
- ChrMT:12383
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12386
- GRCh38:
- ChrMT:12386
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12389
- GRCh38:
- ChrMT:12389
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12397
- GRCh38:
- ChrMT:12397
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12400
- GRCh38:
- ChrMT:12400
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12401
- GRCh38:
- ChrMT:12401
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12403
- GRCh38:
- ChrMT:12403
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12406
- GRCh38:
- ChrMT:12406
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12410
- GRCh38:
- ChrMT:12410
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12418
- GRCh38:
- ChrMT:12418
| MT-ND5 | | Mitochondrial myopathy with reversible cytochrome C oxidase deficiency, Leber optic atrophy, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke
| Pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:12424
- GRCh38:
- ChrMT:12424
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12425
- GRCh38:
- ChrMT:12425
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12426
- GRCh38:
- ChrMT:12426
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12432
- GRCh38:
- ChrMT:12432
| MT-ND5 | | not provided | Uncertain significance (Dec 22, 2015) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12436
- GRCh38:
- ChrMT:12436
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12437
- GRCh38:
- ChrMT:12437
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12448
- GRCh38:
- ChrMT:12448
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12448
- GRCh38:
- ChrMT:12448
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12451
- GRCh38:
- ChrMT:12451
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12454
- GRCh38:
- ChrMT:12454
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12457
- GRCh38:
- ChrMT:12457
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12458
- GRCh38:
- ChrMT:12458
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12479
- GRCh38:
- ChrMT:12479
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12481
- GRCh38:
- ChrMT:12481
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12481
- GRCh38:
- ChrMT:12481
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12490
- GRCh38:
- ChrMT:12490
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12493
- GRCh38:
- ChrMT:12493
| MT-ND5 | | not provided | Uncertain significance (Apr 11, 2017) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12499
- GRCh38:
- ChrMT:12499
| MT-ND5 | | not provided | not provided | no assertion provided |
| - GRCh37:
- ChrMT:12501
- GRCh38:
- ChrMT:12501
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12509
- GRCh38:
- ChrMT:12509
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12512
- GRCh38:
- ChrMT:12512
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12520
- GRCh38:
- ChrMT:12520
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12530
- GRCh38:
- ChrMT:12530
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12535
- GRCh38:
- ChrMT:12535
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12542
- GRCh38:
- ChrMT:12542
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12544
- GRCh38:
- ChrMT:12544
| MT-ND5 | | Mitochondrial disease | Uncertain significance (Dec 10, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:12545
- GRCh38:
- ChrMT:12545
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12556
- GRCh38:
- ChrMT:12556
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12557
- GRCh38:
- ChrMT:12557
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12560
- GRCh38:
- ChrMT:12560
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12561
- GRCh38:
- ChrMT:12561
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12587
- GRCh38:
- ChrMT:12587
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12599
- GRCh38:
- ChrMT:12599
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12601
- GRCh38:
- ChrMT:12601
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12613
- GRCh38:
- ChrMT:12613
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12622
- GRCh38:
- ChrMT:12622
| MT-ND5 | | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12631
- GRCh38:
- ChrMT:12631
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12634
- GRCh38:
- ChrMT:12634
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12661
- GRCh38:
- ChrMT:12661
| MT-ND5 | N109Y | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12662
- GRCh38:
- ChrMT:12662
| MT-ND5 | N109S | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12673
- GRCh38:
- ChrMT:12673
| MT-ND5 | N113D | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12674
- GRCh38:
- ChrMT:12674
| MT-ND5 | N113S | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12681
- GRCh38:
- ChrMT:12681
| MT-ND5 | | not provided | Likely benign (Aug 12, 2015) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12706
- GRCh38:
- ChrMT:12706
| MT-ND5 | F124L | Mitochondrial disease | Likely pathogenic (Jun 30, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:12713
- GRCh38:
- ChrMT:12713
| MT-ND5 | I126T | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12715
- GRCh38:
- ChrMT:12715
| MT-ND5 | T127A | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12730
- GRCh38:
- ChrMT:12730
| MT-ND5 | V132I | Leigh syndrome | Likely benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12743
- GRCh38:
- ChrMT:12743
| MT-ND5 | N136S | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12757
- GRCh38:
- ChrMT:12757
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12770
- GRCh38:
- ChrMT:12770
| MT-ND5 | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Pathogenic (Jan 1, 2003) | no assertion criteria provided |
| - GRCh37:
- ChrMT:12775
- GRCh38:
- ChrMT:12775
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12797
- GRCh38:
- ChrMT:12797
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12799
- GRCh38:
- ChrMT:12799
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12810
- GRCh38:
- ChrMT:12810
| MT-ND5 | | not provided | Likely benign (Aug 12, 2015) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12811
- GRCh38:
- ChrMT:12811
| MT-ND5 | | Mitochondrial disease | Benign (Apr 17, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:12814
- GRCh38:
- ChrMT:12814
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12820
- GRCh38:
- ChrMT:12820
| MT-ND5 | | Leigh syndrome | Benign (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12835
- GRCh38:
- ChrMT:12835
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12836
- GRCh38:
- ChrMT:12836
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12842
- GRCh38:
- ChrMT:12842
| MT-ND5 | | Leigh syndrome | Uncertain significance (Oct 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:12848
- GRCh38:
- ChrMT:12848
| MT-ND5 | | Leber optic atrophy | Pathogenic (Nov 1, 2005) | no assertion criteria provided |